University of Ioannina
Νευροβιολογικές παράμετροι στην προσέγγιση δεικτών συσχέτισης με το πρώτο ψυχωτικό επεισόδιο
Abstract
dc:descriptionThe aim of this study was to investigate four polymorphisms (Val158Met, A644G, 5-HTTLPR and Val66Met) in COMT, MAOB, 5-HTT and BDNF genes respectively, in drug-naïve schizophrenic patients with first-episode psychosis (FEP) and healthy participants. In addition, serum BDNF levels were compared between patients and healthy participants. Finally, differences in patients’ psychopathology related to different genotypes, have been investigated for each polymorphism. This cross-sectional study, included 67 FEP patients recruited by the Early Intervention Service (EIS) for Psychosis of the Department of Psychiatry, Medical School, University of Ioannina, Greece and 76 healthy participants, who served as controls. Concerning Val158Met polymorphism, FEP patients presented a higher frequency of Val/Val homozygotes than healthy participants. The odds of being assessed with FEP, were 2.2 times higher in Val/Val patients. Moreover, Val/Val patients presented higher PANSS total scores, as compared to Met carriers.There was not any statistically significant difference concerning A644G polymorphism.Concerning 5-HTTLPR polymorphism, our results presented a higher frequency of l/l homozygotes in FEP patients. The odds of being assessed with FEP were 2.6 times higher in patients with an l/l genotype. As far as Val66Met polymorphism is concerned, there weren't any differences between patients and healthy participants. FEP patients presented lower BDNF serum concentrations, as compared to healthy participants. In particular, Met carriers had lower BDNF serum concentrations and higher PANSS-Negative Syndrome Scale scores than Val/Val homozygotes. Present results confirm and extend previous findings related to the complex genetic substrate underlying schizophrenia and first psychotic episode. However, our study has specific limitations which need to be carefully addressed. In particular, current findings must be carefully interpreted due to the cross-sectional design of the study and the limited sample size. On the other hand, strengths of our study include the healthy control sample, the use of widely used validated questionnaires and the fact that our patients were drug-naive, and they were assessed by the same experienced clinicians. Nevertheless, further prospective studies based on larger sample sizes adequately powered with specific clinical assessments and gene-environment interactions, are needed to replicate and extend current findings.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Sotiropoulou, Marianthi
- Σωτηροπούλου, Μαριάνθη
Subjects
dc:subject × 20- Ασθενείς πρώτου επεισοδίου
- Σχιζοφρένεια
- Πολυμορφισμός ενός νουκλεοτιδίου
- Κατεχολ-ο-μεθυλτρανσφεράση
- Προερχόμενος από τον εγκέφαλο νευροτροφικός παράγοντας
- Μεταφορέας της σεροτονίνης
- Μονοαμινο-οξειδάση Β
- Κλίμακα θετικών και αρνητικών συμπτωμάτων της ψύχωσης
- First episode psychosis
- Drug naive schizophrenic patients
- Single nucleotide polymorphisms
- Catechol-0-methyltransferase
- Brain-derived neurotrophic factor
- Monoamine oxidase B
- Serotonin transporter
- Positive and negative syndrome scale (PANSS)
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες Υγείας
- Medical and Health Sciences
- Health Sciences
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/33133